DexCare scoops up $50M and different digital well being fundings

DexCare scored $50 million in a Collection B funding spherical led by Transformation Capital. Present traders Kaiser Permanente, Windfall Ventures, Mass Normal Brigham, Outline Ventures, Frist Cressey Ventures and SpringRock Ventures additionally participated. 

The Collection B comes lower than a yr after a $20 million fundraise from March

The Windfall Well being spinout gives a platform for well being methods to seek out new sufferers, navigate their care and handle staffing and sources to satisfy demand. 

“Hospitals are transferring to hybrid care and wish a single resolution to draw new sufferers and to attach them each just about and in-person with their very own caregivers,” cofounder and CEO Derek Streat mentioned in an announcement.

“This funding will assist us speed up platform growth and go-to-market progress for our rising variety of premier well being methods comparable to Kaiser Permanente, Windfall, Mass Normal Brigham, CHS, Houston Methodist and others. Transformation Capital’s digital well being focus will assist us obtain these objectives together with our present line-up of prime healthcare-focused companions.”

DeepScribe, an AI-enabled medical documentation device for healthcare suppliers, raised $30 million in funding.

The spherical was led by Nina Achadjian at Index Ventures, with participation from CEO Figma CEO Dylan Area and current traders Bee Companions, Stage 2 Capital and 1984 Ventures.

The corporate closed a $5.2 million seed spherical in Could. Based on Cruchbase, DeepScribe’s complete increase is now $37.2 million. 

“We consider that ambient voice know-how is the important thing to transcending AI in drugs from merely delivering workflow efficiencies to truly bettering healthcare outcomes,” cofounders Akilesh Bapu and Matthew Ko mentioned in an announcement.

“Doctor-patient conversations have probably the most wealthy info, however busy, burned out clinicians don’t have the bandwidth to doc all of this knowledge and do something significant with it. DeepScribe goals to vary that.”

AI-enabled most cancers danger stratification platform PreciseDx has raised $10.75 million in a Collection A financing spherical led by the Merck International Well being Innovation Fund.

Different traders collaborating embrace Mount Sinai Well being System, Agilent Applied sciences, IBM Ventures and the Hobart Group. 

The corporate plans to make use of the money to develop and commercialize further most cancers diagnostics and to help medical trials. 

“Merck GHI is happy to help PreciseDx as they assist speed up the digitization of pathology,” David M. Rubin, PhD, managing director of Merck GHI, mentioned in an announcement. “AI-enabled, customized healthcare is the long run. We consider the power to create and leverage billions of novel knowledge factors has the potential to really change most cancers therapy.”

Care coordination startup HeyRenee scored $4.4 million in Seed II funding.

The spherical was led by Quiet Capital, with participation from Metropolis Mild Capital, Fika Ventures, International Founders Capital, Mucker Capital, SaaS Ventures and Tau Ventures. The corporate mentioned its complete increase is now $8.2 million, and it plans to launch its service in early spring this yr. 

“HeyRenee is a private healthcare assistant that unifies the myriad complicated elements of healthcare into one intuitive, pleasant expertise particularly designed for underprivileged, older People who typically have decrease well being and tech literacy and a number of well being, social and cultural elements that require coordinated consideration to comprehend improved outcomes,” cofounder and CEO Nick Desai mentioned in an announcement.

“Quiet Capital and Morgan Livermore are exceptionally excessive value-added lead traders. Together with Fika, Tau and our different traders, they gas our unrelenting pursuit of well being fairness for all People.”

Supply hyperlink

What's your reaction?

In Love
Not Sure

You may also like

More in:Health

Leave a reply

Your email address will not be published. Required fields are marked *